4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-058820
Chief Executive Officer sold 7,800 shares at an average $34.62 ($270,052)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-11-14 | Sale : show line 1 in the form | −3,300 | $33.89 | $111,837 | 39,778 | I |
| 2018-11-14 | Sale : show line 2 in the form | −600 | $34.51 | $20,706 | 39,178 | I |
| 2018-11-15 | Sale : show line 3 in the form | −1,100 | $34.67 | $38,137 | 38,078 | I |
| 2018-11-15 | Sale : show line 4 in the form | −2,800 | $35.49 | $99,372 | 35,278 | I |
| Open-market sales · 7,800 sh · avg $34.62 · $270,052 | ||||||
Loading xslF345X03/doc4.xml…